Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In a phase 2 study, comparing the results of the empagliflozin arm to the control arm showed a significant improvement in the electrophysiological studies and a significant decrease in the pain score and the mean serum levels of neuron-specific enolase and malondialdehyde in patients with DPN
JNK/Bim, Wnt/-Catenin, PI3K/AKT and ERK/TFEB signaling pathways have been demonstrated to modulate TECs apoptosis in DKD (114117)
Copyright 2025 Guideline Central, All Rights Reserved.
The fastest we increase the dose is once a month, Dr
US$ 22.30
US$ 22.48
US$ 27.24
US$ 25.17
